Immunotherapy with Pru p 3 for food allergy to peach and non-specific lipid transfer protein: a systematic review

• Review
• Open Access

• Carlo Maria Rossi, 
• Marco Vincenzo Lenti, 
• Stefania Merli, 
• Amelia Licari, 
• Gian Luigi Marseglia & 
• Antonio Di Sabatino 

Clinical and Molecular Allergy volume 21, Article number: 3 (2023) 

• details

Abstract

Background

Non-specific lipid-transfer protein (nsLTP) is a pan-allergen in the plant world, and a cause of significant concern as food allergen in the Mediterranean area, due to its general heat- and acid-resistance and hence the risk of severe allergic reactions. Pru p 3, the peach nsLTP, is considered the primary sensitizer to this allergen family and this allergy is usually persistent. Allergen-free diet and acute treatment of manifestations are the main recognized management goals in food allergy.

Main text

The role of immunotherapy for treating food allergy in adult patients is controversial, but immunotherapy for Pru p 3 could potentially represent a relevant therapeutic strategy. We systematically searched databases for studies assessing the role of immunotherapy Pru p 3 in food allergy. Overall, nine studies were included. Immunotherapy with Pru p 3 appears to be effective and with a good safety profile in both peach and LTP allergy for some foods, such as peanut, in both RCT and real-life studies.

Conclusions

Immunotherapy with Pru p 3 is a possible treatment option for food allergy to the peach LTP in the Mediterranean area, although at present have not reached routinary clinical practice. Larger studies are needed to confirm these findings and identify predictive biomarkers.

Download PDF